Renewing Arcalyst (Rilonacept) Approval with Blue Cross Blue Shield in New Jersey: Complete Guide for 2025
Answer Box: Renewing Arcalyst Coverage in New Jersey
Blue Cross Blue Shield renewal of Arcalyst (rilonacept) requires updated clinical documentation showing therapeutic benefit 30 days before your current authorization expires. Key requirements include evidence of symptom improvement, normalized inflammatory markers (CRP/SAA), and lipid monitoring results. Submit renewal documentation through